In addition, the high-risk group had universally lower immune cell counts and activities than the low-risk group, such as NK cells, CD8+ T cells, and type I IFN response, which could suppress tumor proliferation and metastasis (Henning et al., 2018; Hodgins et al., 2019; Liang et al., 2021). Here, CD8A is linked to neoplasm.